Nutex Health Inc.
NUTXNutex Health Inc. is a physician-led healthcare services and operations company that integrates a network of micro-hospitals with a population health management platform.
Earnings
Next report
Nov 17, 2026 (in 2 months)Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
Profile
Nutex Health Inc. is a physician-led healthcare services and operations company that integrates a network of micro-hospitals with a population health management platform. The company specializes in providing concierge-level emergency and inpatient care through a decentralized model while managing risk-bearing provider networks. Its core value proposition centers on reducing patient wait times and aligning financial incentives with physician partners through co-ownership of facilities.
Nutex occupies a niche as a leading operator of micro-hospitals, competing against traditional large hospital systems by offering lower wait times and a physician-partnership equity model.
FAQ
- What is Nutex Health Inc.'s market cap?
- Nutex Health Inc. (NUTX) has a market capitalization of $1.5B and trades on NASDAQ.
- What is Nutex Health Inc.'s revenue and profitability?
- Nutex Health Inc. generated $846.7M in trailing twelve-month revenue with net income of $179.9M, representing a net margin of 21.2%. Gross margin stands at 51.3%, with free cash flow of $274.2M. The latest reported period is Q2 2026.
- Who are Nutex Health Inc.'s competitors?
- Nutex Health Inc.'s key competitors include Tenet Healthcare, HCA Healthcare, National Healthcare Corp., and others. These companies compete in similar markets and product categories.
- Who does Nutex Health Inc. partner with?
- Nutex Health Inc.'s notable partners include HaloMD.
- What subsidiaries does Nutex Health Inc. have?
- Nutex Health Inc.'s subsidiaries include Physician LLCs, Real Estate Entities.
- Where is Nutex Health Inc. headquartered?
- Nutex Health Inc. is headquartered in United States of America and employs approximately 800 people. It has been publicly traded since 2022.
